Recruiting
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
NCT07339774· Phase 2· West China Hospital· Source
Contact: Xingchen Peng Ph.D
Recruiting
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery
NCT07676890· Phase 1· West China Hospital· Source
Contact: Xuelei Ma, MD
Recruiting
Wireless Wearable Home Prehabilitation for Older Adults With NSCLC
NCT07809763· West China Hospital· Source
Contact: Xuelei Ma
Recruiting
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery
NCT07724106· Phase 1· West China Hospital· Source
Contact: Xuelei Ma, MD
Recruiting
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
NCT07076836· West China Hospital· Source
Contact: Nan Lin
Not yet recruiting
Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection
NCT07797075· West China Hospital· Source
Contact: Xuelei ma
Not yet recruiting
Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
NCT07733492· West China Hospital· Source
Contact: Xuelei ma
Not yet recruiting
YMN-A02 for Advanced pMMR Colorectal Cancer With Liver Metastases
NCT07610707· Phase 1· West China Hospital· Source
Contact: Peng Xingchen Professor
Not yet recruiting
YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
NCT07580261· Phase 1· West China Hospital· Source
Contact: Peng Xingchen Professor
Recruiting
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
NCT07767630· Early phase 1· Sichuan University· Source
Contact: Rong TIAN
Recruiting
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07381075· Phase 2· West China Hospital· Source
Contact: Xiaoyuan Wei, PhD
Not yet recruiting
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
NCT07665359· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Chengdi Wang
Recruiting
Adaptive DBS for PD
NCT07635823· Beijing Pins Medical Co., Ltd· Source
Contact: Wei Wang (principal investigator)
Recruiting
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
NCT07463248· Phase 2· Wang Xin· Source
Contact: Feng Wen
Recruiting
BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT07318948· Bo Wu· Source
Contact: Bo Wu, Doctor
Recruiting
Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
NCT07625423· Phase 1· West China Hospital· Source
Contact: Xuelei ma
Recruiting
Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
NCT07282483· Phase 2· West China Hospital· Source
Contact: Xingchen Peng, Ph.D
Recruiting
HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management
NCT07402239· United Innomed(Shanghai) Limited· Source
Contact: CHEN Mao
Recruiting
H101 Plus TACE for r/m HNSCC
NCT07398664· Phase 2· West China Hospital· Source
Contact: Tao Hai
Recruiting
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275· West China Hospital· Source
Contact: Jiwei Huang Professor
Recruiting
The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
NCT07310056· West China Hospital· Source
Contact: Cyan Dr
Recruiting
Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
NCT07295340· West China Hospital· Source
Contact: Jiwei Huang Professor
Recruiting
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
NCT07295262· Early phase 1· West China Hospital· Source
Contact: Jiwei Huang Professor
Active, not recruiting
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT07216976· MedtronicNeuro· Source
Recruiting
PULSAR Combined With Immunotherapy and Chemotherapy
NCT07291947· Phase 1/2· Wang Xin· Source
Contact: shu pei
Not yet recruiting
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
NCT07201259· West China Second University Hospital· Source
Contact: Xuelei Ma
Recruiting
A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
NCT06753747· Phase 1/2· West China Hospital· Source
Contact: Jin Zhou
Recruiting
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
NCT07106827· Phase 1· West China Hospital· Source
Contact: Jin Zhou
Recruiting
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345· Chinese Academy of Sciences· Source
Contact: Hanyu Jiang
Active, not recruiting
Assessment of DOT Spectacles in Chinese Children Extension
NCT07008001· SightGlass Vision, Inc.· Source
Recruiting
Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
NCT07076823· Phase 1· West China Hospital· Source
Contact: Nan Lin
Not yet recruiting
Inverted-Ω Anastomosis in Laparoscopic Duodenum-Preserving Pancreatic Head Resection or Laparoscopic Central Pancreatectomy
NCT07087392· West China Hospital· Source
Contact: Zhong Wu
Recruiting
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
NCT07067346· Early phase 1· Sichuan University· Source
Contact: Xiaoai Wu, Phd
Not yet recruiting
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
NCT06804863· West China Hospital· Source
Contact: Jianyong Lei, MD
Active, not recruiting
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543· Phase 3· Chengdu New Radiomedicine Technology Co. LTD.· Source
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814· West China Hospital· Source
Contact: Jiwei Huang Huang Professor
Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
NCT06950827· West China Hospital· Source
Contact: Jiwei Huang Huang Professor
Enrolling by invitation
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
NCT06966687· Nanjing Medical University· Source
Recruiting
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
NCT06831175· Phase 2· West China Hospital· Source
Contact: Xingchen Peng, PhD
Recruiting
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473· The Eye Hospital of Wenzhou Medical University· Source
Contact: Kai Wang, MD
Not yet recruiting
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
NCT06713057· Phase 2· West China Hospital· Source
Contact: Zhihui Li, Professor
Recruiting
Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)
NCT07070622· Phase 3· West China Hospital· Source
Contact: Wang Ziqiang, PhD
Recruiting
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
NCT06742424· Phase 2· West China Hospital· Source
Contact: Yiwen Qiu, M.D.
Recruiting
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
NCT06787989· Phase 1· iCell Gene Therapeutics· Source
Contact: Qibing Xie, MD
Recruiting
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
NCT06800482· West China Hospital· Source
Contact: Jianyong Lei, MD
Recruiting
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
NCT07463300· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Rong Tian
Recruiting
A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT06444009· Phase 2· Lei Liu· Source
Contact: Lei Liu, M.D.
Recruiting
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
NCT06378242· Phase 1/2· RemeGen Co., Ltd.· Source
Contact: Peng Zhang, M.D
Recruiting
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270· West China Hospital· Source
Contact: Chunling Jiang, PhD
Active, not recruiting
A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB
NCT06308120· Intuitive Surgical· Source
Showing 50 of 67.